Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
King International InvestmentHKSE:00928 PB Ratio is 0.76 as of Aug. 09, 2026, which is 17% above its 10-year median of 0.65. The stock has 5 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, King International Investment ranks better than 87.11% on this metric.
The historical rank and industry rank for King International Investment's PB Ratio or its related term are showing as below:
HKSE:00928'
s PB Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.65 Max: 7.98
Current: 0.75
During the past 13 years, King International Investment's highest PB Ratio was 7.98. The lowest was 0.19. And the median was 0.65.
HKSE:00928's PB Ratio is ranked better than 87.11% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.195
vs HKSE:00928: 0.75
During the past 12 months, King International Investment's average Book Value Per Share Growth Rate was 7.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -5.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -11.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -7.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of King International Investment was 46.80% per year. The lowest was -40.30% per year. And the median was -8.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
King International Investment PB Ratio Related Terms
King International Investment PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, King International Investment's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
King International Investment PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's PB Ratio distribution charts can be found below:
* The bar in red indicates where King International Investment's PB Ratio falls into.
King International Investment PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
King International Investment (HKSE:00928) has a PB Ratio of 0.76 as of Aug. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on King International Investment and its competitors. This is 17% above median its historical median of 0.65. Over the past decade, King International Investment's PB Ratio has ranged from 0.19 to 7.98. According to the industry distribution chart, King International Investment ranks #25 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 12.9%.
Is King International Investment's PB Ratio too high?
King International Investment's current PB Ratio of 0.76 is 17% above median its 10-year median of 0.65. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 7.98. The Medical Diagnostics & Research industry median PB Ratio is 2.20. King International Investment's value of 0.76 is 65.4% below this industry median. Based on the distribution chart, King International Investment ranks #25 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does King International Investment's PB Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, King International Investment ranks #25 out of 194 companies for PB Ratio. This places King International Investment in the top 13% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.20. King International Investment's value of 0.76 is 65.4% below this benchmark. Historically, King International Investment's own PB Ratio has ranged from 0.19 to 7.98 over the past decade. While the company's 10-year median is 0.65 vs. the industry median of 2.20, King International Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 2.20, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. King International Investment's current PB Ratio of 0.76 is 65.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on King International Investment and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. King International Investment's current PB Ratio is 0.76, which is 17% above median its own 10-year median of 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is King International Investment stock overvalued right now?
Based on GuruFocus' analysis, King International Investment (HKSE:00928) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.04, compared to a current price of HK$0.10 — trading 145% above its estimated fair value. The current PB Ratio is 0.76, which is 17% above median its 10-year median of 0.65 and 65.4% below the Medical Diagnostics & Research industry median of 2.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For King International Investment (HKSE:00928), the current PB Ratio is 0.76 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
King International Investment Ltd is an investment holding company. Its operating segments include healthcare products and services, money lending, and liquor sales, with the majority of revenue generated from the liquor sales segment. The group provides genetic testing and develops domestic healthcare equipment services. Leveraging its strengths, the group integrates health data analysis software with healthcare equipment to offer new healthcare services and products. Geographically, it derives the majority of its revenue from the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00928 has been successfully added to your 
